Advancing Telestroke Care: A Prospective Observational Study (ATC)
|ClinicalTrials.gov Identifier: NCT01226862|
Recruitment Status : Completed
First Posted : October 22, 2010
Last Update Posted : December 5, 2013
|Condition or disease|
The goal of this study is to promote the development and economic sustainability of telemedicine for acute stroke treatment. The study's objectives are 1) to determine if the use of telemedicine consultations for stroke patients will improve their care per guidelines compared to stroke patients treated by control hospitals; and 2) to determine if the care per guidelines provided via telemedicine consultations for stroke patients will be similar or equivalent to care per guidelines provided to stroke patients treated at hub hospitals.
The Advancing Telestroke Care study will establish treatment and outcomes in three distinct study cohorts: hub telemedicine hospital, spoke telemedicine hospital and non-telemedicine control hospital.
|Study Type :||Observational|
|Actual Enrollment :||508 participants|
|Official Title:||Advancing Telestroke Care: A Prospective Observational Study|
|Study Start Date :||December 2010|
|Primary Completion Date :||May 2013|
|Study Completion Date :||December 2013|
Hub Hospital Cohort: Joint Commission-certified Primary Stroke Centers where patients are treated using hospital-based stroke teams and pathways; these hospital personnel also provide telemedicine consultation to satellite hospitals.
Spoke Hospital Cohort: non-stroke center certified sites, where patients are treated at an in-network telestroke community hospital using telemedicine technology with consultation provided by physicians from a hub hospital.
Control Hospital Cohort: non-stroke center certified sites with no telemedicine services.
- IV tPA administration [ Time Frame: Day 7/Discharge ]Correctness of decisions regarding IV tPA administration in acute stroke
- Multiple Study Assessments [ Time Frame: Day 7 and/or Day 30 and/or Day 90 and/or at discharge ]There are 23 assessments, after stroke, for outcome measures. They include: hospital transfers, treatment with reperfusions therapies, treatment with antiplatelets, hypertension treatment, hyperglycemia treatment, hyperlipidemia treatment, symptomatic ICH, mortality, imaging/diagnostic data, stroke and rehab scale scores, number of hospitalizations since last assessment, hospital LOS, discharge location, number of physician visits, and work status.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01226862
|United States, California|
|University of Southern California|
|Los Angeles, California, United States, 90033|
|Principal Investigator:||Gene Sung, MD, MPH||University of Southern California, Los Angeles|